AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)
World

WHO expects assessment of Moderna and two Chinese vaccines by end of next week

  • Simao said the WHO's independent panel was assessing the Moderna vaccine and a vaccine from China's Sinopharm on Friday and was due to look at China's other main vaccine, made by Sinovac Biotech, next week.
  • "So, by the beginning of next week or the end of next week we will have the final assessment of these three vaccines out," she told a briefing.
Published April 30, 2021

GENEVA: The World Health Organization expects to release its assessments for emergency use listing of the two main Chinese vaccines for COVID-19 as well as the Moderna shot by the end of next week, WHO Assistant Director-General Mariangela Simao said on Friday.

Simao said the WHO's independent panel was assessing the Moderna vaccine and a vaccine from China's Sinopharm on Friday and was due to look at China's other main vaccine, made by Sinovac Biotech, next week.

"So, by the beginning of next week or the end of next week we will have the final assessment of these three vaccines out," she told a briefing.

WHO emergency use listing is a signal to national regulators that a vaccine is safe and effective, and would allow those vaccines to be bought and distributed by COVAX, the international programme to share vaccines for poor countries.

Simao said it was important to have more vaccines available because of supply problems for other shots, including from India, a main source of vaccines for COVAX which has restricted exports because of a surge in domestic cases.

If approved, China's two vaccines would be the first developed in a non-Western country to receive the WHO's backing.

China has already deployed millions of doses of both its main vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa.

So far, the WHO has given emergency use listing to three shots against COVID-19, made by Pfizer, AstraZeneca and Johnson & Johnson.

Comments

Comments are closed.